The following questions provide general scientific and product information about KPV and the analytical documentation associated with Whitey’s Peps research materials.
KPV is a tripeptide composed of lysine, proline, and valine. It corresponds to the C-terminal sequence of α-melanocyte-stimulating hormone (α-MSH) and has been investigated primarily in preclinical research.
Research has examined KPV primarily in relation to inflammatory signaling, intestinal inflammation, and cellular responses involved in tissue protection.
Experimental research has examined the transport of KPV into intestinal epithelial and immune cells through the peptide transporter PepT1, as well as its effects on intracellular inflammatory signaling.
Research has examined KPV in relation to NF-κB and MAPK signaling pathways and changes in inflammatory cytokine production in experimental cell models.
The available evidence for KPV is predominantly preclinical, with research involving cell and animal models. These findings should not automatically be interpreted as demonstrating the same effects in humans.
Where applicable, independent laboratory documentation may provide information about product identity, purity, and other analytical characteristics of a tested batch. Analytical results apply only to the specific sample or batch identified in the applicable laboratory documentation.